q.beyond Q2 FY26 turns to net loss of €0.9 million; revenue falls 3.15% to €43 million
Reuters2026/08/10 05:32- q.beyond Q2 2026 revenue fell 3.15% to € 43 million, while consolidated net income swung to a € 0.9 million loss.
- EBITDA dropped 40.74% to € 1.6 million, while adjusted EBITDA margin held at 6% with adjusted EBITDA of € 2.5 million.
- Free cash flow turned negative at € -1.6 million, while net liquidity rose to € 41 million at June 30.
- Management flagged one-off AI transformation expenses of around € 5 million to € 6 million, targeting about € 7 million annual savings from 2027.
- 2026 outlook cut to € 176 million-€ 180 million revenue, EBITDA seen at € 3 million-€ 7 million; share buybacks planned from late August.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)
A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.
Crypto prices
More
